Universidad de Zaragoza-ko ikertzaileekin lankidetzan egindako argitalpenak (29)

2024

  1. A Review on the Methodology and Use of the Pregnant Mouse Model in the Study of Brucella Reproductive Pathogenesis and Its Abortifacient Effect

    Microorganisms, Vol. 12, Núm. 5

2023

  1. A review of three decades of use of the cattle brucellosis rough vaccine Brucella abortus RB51: myths and facts

    BMC Veterinary Research, Vol. 19, Núm. 1

  2. Characterization of three predicted zinc exporters in Brucella ovis identifies ZntR-ZntA as a powerful zinc and cadmium efflux system not required for virulence and unveils pathogenic Brucellae heterogeneity in zinc homeostasis

    Frontiers in Veterinary Science, Vol. 10

2022

  1. A Brucella melitensis H38ΔwbkF rough mutant protects against Brucella ovis in rams

    Veterinary research, Vol. 53, Núm. 1, pp. 16

  2. Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry

    Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 260-266

2021

  1. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7

  2. The Phospholipid N-Methyltransferase and Phosphatidylcholine Synthase Pathways and the ChoXWV Choline Uptake System Involved in Phosphatidylcholine Synthesis Are Widely Conserved in Most, but Not All Brucella Species

    Frontiers in Microbiology, Vol. 12

  3. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. Development of attenuated live vaccine candidates against swine brucellosis in a non-zoonotic B. suis biovar 2 background

    Veterinary Research, Vol. 51, Núm. 1

  2. Erratum: Rev1 wbdR tagged vaccines against Brucella ovis (Veterinary Research (2019) 50 (95) DOI: 10.1186/s13567-019-0714-3)

    Veterinary Research

  3. Glucose Oxidation to Pyruvate Is Not Essential for Brucella suis Biovar 5 Virulence in the Mouse Model

    Frontiers in Microbiology, Vol. 11

  4. Ivermectin and COVID-19: Keeping rigor in times of urgency

    American Journal of Tropical Medicine and Hygiene

  5. The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Corrigendum: Genetic and Phenotypic Characterization of the Etiological Agent of Canine Orchiepididymitis Smooth Brucella sp. BCCN84.3 (Frontiers in Veterinary Science, (2019), 6, 10.3389/fvets.2019.00175)

    Frontiers in Veterinary Science

  2. Genetic and phenotypic characterization of the etiological agent of canine orchiepididymitis smooth Brucella sp. BCCN84.3

    Frontiers in Veterinary Science, Vol. 6, Núm. JUN

  3. Rev1 wbdR tagged vaccines against Brucella ovis

    Veterinary Research, Vol. 50, Núm. 1

2018

  1. A systematic review of current immunological tests for the diagnosis of cattle brucellosis

    Preventive Veterinary Medicine, Vol. 151, pp. 57-72

  2. The fast-growing Brucella suis Biovar 5 depends on phosphoenolpyruvate carboxykinase and pyruvate phosphate dikinase but not on Fbp and GlpX fructose-1,6-bisphosphatases or isocitrate lyase for full virulence in laboratory models

    Frontiers in Microbiology, Vol. 9, Núm. APR

  3. The prevalence of brucellosis and bovine tuberculosis in ruminants in Sidi Kacem Province, Morocco

    PLoS ONE, Vol. 13, Núm. 9

  4. WadD, a New Brucella Lipopolysaccharide Core Glycosyltransferase Identified by Genomic Search and Phenotypic Characterization

    Frontiers in Microbiology, Vol. 9